×
Omnicell Receivables 2010-2025 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Omnicell receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Omnicell Receivables 2010-2025 | OMCL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Omnicell receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.7B
Hims & Hers Health (HIMS)
$13B
Doximity (DOCS)
$11.5B
Tempus AI (TEM)
$11.2B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.9B
Hinge Health (HNGE)
$3.7B
Privia Health (PRVA)
$2.5B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.7B
10x Genomics (TXG)
$1.7B
Phreesia (PHR)
$1.6B
Enovis (ENOV)
$1.6B
Azenta (AZTA)
$1.6B
Evolent Health (EVH)
$1.2B
Claritev (CTEV)
$719M
Fulgent Genetics (FLGT)
$575M
Standard BioTools (LAB)
$551M
Butterfly Network (BFLY)
$532M
Veradigm (MDRX)
$503M
Talkspace (TALK)
$438M
TruBridge (TBRG)
$347M
Outset Medical (OM)
$345M
Health Catalyst (HCAT)
$282M
Nyxoah SA (NYXH)
$265M
SOPHiA GENETICS SA (SOPH)
$241M
CapsoVision (CV)
$197M
Zepp Health (ZEPP)
$176M
KORU Medical Systems (KRMD)
$164M
Pulmonx (LUNG)
$152M